small molecule

MITOXANTRONE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity

CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand name	MITOXANTRONE HYDROCHLORIDE
Active ingredient	MITOXANTRONE HYDROCHLORIDE
Strength	EQ 20MG BASE/10ML (EQ 2MG BASE/ML)
Dosage form	INJECTABLE
Route	INJECTION
Modality	Small molecule
FDA approval	April 2006
Marketing status	RX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.